Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

What Cramer Thinks About Hims & Hers Health, Gilead Sciences And More

Author: Craig Jones | March 21, 2022 08:34am

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Healthcare Realty Trust Incorporated (NYSE:HR) as the company’s merger with Healthcare Trust of America, Inc. (NYSE:HTA) "made a lot of sense."

When asked about Two Harbors Investment Corp. (NYSE:TWO), Cramer said he has seen several companies like that. "I’m not going there," he added.

The "Mad Money" host said Hims & Hers Health, Inc. (NYSE:HIMS) loses money, and he is not recommending stocks that are losing a lot of money.

When asked about Shell Midstream Partners, L.P. (NYSE:SHLX), he said Enterprise Products Partners L.P. (NYSE:EPD) is the "best one if you want to be in that group now."

Also See: Is GameStop Headed To $25? Jim Cramer Weighs In Following Q4 Earnings

Cramer said Gilead Sciences, Inc. (NASDAQ:GILD) looks very cheap, but that’s not the reason why drug stocks are bought. "We buy drug stocks because they’ve got growth, and Gilead has none," he commented.

When asked about DraftKings Inc. (NASDAQ:DKNG), he said, "Jim Chanos says it’s a great short. I think the time to short the stock was much, much higher."

Photo: Courtesy of Owen Byrne on Flickr

Posted In: DKNG EPD GILD HIMS HR HTA SHLX TWO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist